Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Cinacalcet products are in shortage in Canada (10 of 24 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Dec 31, 2026.
A medication used to lower overactive parathyroid hormone and calcium levels, often in people with kidney disease.
Products affected
10 / 24
In shortage since
Mar 10, 2024
Est. full return
Dec 31, 2026
Reports on file
70
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
APO-CINACALCET
30MG · TABLET · APOTEX INC
DIN 02452693 · since Apr 28, 2026, est. end Jun 19, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-CINACALCET
90MG · TABLET · TEVA CANADA LIMITED
DIN 02441640 · since Mar 10, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TEVA-CINACALCET
60MG · TABLET · TEVA CANADA LIMITED
DIN 02441632 · since Mar 10, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TEVA-CINACALCET
30MG · TABLET · TEVA CANADA LIMITED
DIN 02441624 · since Mar 10, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
MYLAN-CINACALCET
90MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02434555 · since Mar 23, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortage
MYLAN-CINACALCET
60MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02434547 · since Sep 20, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
PMS-CINACALCET
90MG · TABLET · PHARMASCIENCE INC
DIN 02517620 · since Dec 19, 2024, est. end Dec 31, 2026 · Disruption of the manufacture of the drug.
Active shortage
PMS-CINACALCET
60MG · TABLET · PHARMASCIENCE INC
DIN 02517612 · since Dec 19, 2024, est. end Dec 31, 2026 · Disruption of the manufacture of the drug.
Active shortage
PMS-CINACALCET
30MG · TABLET · PHARMASCIENCE INC
DIN 02517604 · since Dec 19, 2024, est. end Dec 31, 2026 · Disruption of the manufacture of the drug.
Active shortage
MYLAN-CINACALCET
30MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02434539 · since Mar 3, 2025, no end estimate · Disruption of the manufacture of the drug.
Resolved
JAMP CINACALCET TABLETS
30MG · TABLET · JAMP PHARMA CORPORATION
DIN 02500094 · ended Oct 7, 2025 · Disruption of the manufacture of the drug.
Resolved
JAMP CINACALCET TABLETS
60MG · TABLET · JAMP PHARMA CORPORATION
DIN 02500108 · ended Oct 7, 2025 · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Cinacalcet is currently affected by 10 active shortage reports filed with Health Canada by APOTEX INC, TEVA CANADA LIMITED, MYLAN PHARMACEUTICALS ULC, PHARMASCIENCE INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Cinacalcet is classified under “ANTI-PARATHYROID HORMONES” (ATC H05BX).
Recent changes
No changes recorded yet.
Common questions
What is Cinacalcet used for?
A medication used to lower overactive parathyroid hormone and calcium levels, often in people with kidney disease.
When will Cinacalcet be back in stock in Canada?
The latest manufacturer estimate is Dec 31, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Cinacalcet in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.